These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 33819378)
1. Genomics and epigenomics of addiction. Maldonado R; Calvé P; García-Blanco A; Domingo-Rodriguez L; Senabre E; Martín-García E Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):128-139. PubMed ID: 33819378 [TBL] [Abstract][Full Text] [Related]
2. Genomics and epigenomics of substance use disorders: An introduction. Cormand B; Cabana-Domínguez J; Forero DA; Fernàndez-Castillo N Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):125-127. PubMed ID: 33973715 [No Abstract] [Full Text] [Related]
3. Epigenetics and addiction. Hamilton PJ; Nestler EJ Curr Opin Neurobiol; 2019 Dec; 59():128-136. PubMed ID: 31255844 [TBL] [Abstract][Full Text] [Related]
4. Genetic Markers in Psychiatry. Nedic Erjavec G; Svob Strac D; Tudor L; Konjevod M; Sagud M; Pivac N Adv Exp Med Biol; 2019; 1192():53-93. PubMed ID: 31705490 [TBL] [Abstract][Full Text] [Related]
5. Drugs and addiction: an introduction to epigenetics. Wong CC; Mill J; Fernandes C Addiction; 2011 Mar; 106(3):480-9. PubMed ID: 21205049 [TBL] [Abstract][Full Text] [Related]
6. Genomics and epigenomics in rheumatic diseases: what do they provide in terms of diagnosis and disease management? Castro-Santos P; Díaz-Peña R Clin Rheumatol; 2017 Sep; 36(9):1935-1947. PubMed ID: 28725948 [TBL] [Abstract][Full Text] [Related]
7. Pathways from epigenomics and glycobiology towards novel biomarkers of addiction and its radical cure. Reece AS; Wang W; Hulse GK Med Hypotheses; 2018 Jul; 116():10-21. PubMed ID: 29857889 [TBL] [Abstract][Full Text] [Related]
8. Unfolding the pathogenesis of scleroderma through genomics and epigenomics. Tsou PS; Sawalha AH J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340 [TBL] [Abstract][Full Text] [Related]
9. Cross-talk between the epigenome and neural circuits in drug addiction. Mews P; Calipari ES Prog Brain Res; 2017; 235():19-63. PubMed ID: 29054289 [TBL] [Abstract][Full Text] [Related]
10. Neural markers of genetic vulnerability to drug addiction. Müller DJ; Likhodi O; Heinz A Curr Top Behav Neurosci; 2010; 3():277-99. PubMed ID: 21161757 [TBL] [Abstract][Full Text] [Related]
11. Genetic contributions to addiction. Crabbe JC Annu Rev Psychol; 2002; 53():435-62. PubMed ID: 11752492 [TBL] [Abstract][Full Text] [Related]
12. Biochemical Diagnosis in Substance and Non-substance Addiction. Shen W; Liu H; Xie X; Liu H; Zhou W Adv Exp Med Biol; 2017; 1010():169-202. PubMed ID: 29098673 [TBL] [Abstract][Full Text] [Related]
13. Neuroscience of resilience and vulnerability for addiction medicine: From genes to behavior. Morrow JD; Flagel SB Prog Brain Res; 2016; 223():3-18. PubMed ID: 26806768 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms in drug addiction. Renthal W; Nestler EJ Trends Mol Med; 2008 Aug; 14(8):341-50. PubMed ID: 18635399 [TBL] [Abstract][Full Text] [Related]